載入...
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
BACKGROUND: Existing research shows that ABT-199, as a first-line drug, have been widely used in hematological malignancies, especially in leukemia, but the clinical efficacy of single drug therapy was limited part of the reason was that BCL-2 inhibitors failure to target other anti-apoptotic BCL-2...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8317985/ https://ncbi.nlm.nih.gov/pubmed/34336680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.692497 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|